Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: Emergence of Citrobacter freundii as a common microorganism

Burns

Volumn 34, Issue 7, 2008, Pages 947-952

  Khorasani, G ^a   Salehifar, E ^a   Eslami, G ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial resistance; Burn; Citrobacter freundii; Pseudomonas aeruginosa; Wound infection

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; OFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD SAMPLING; BURN; BURN INFECTION; CITROBACTER; CITROBACTER FREUNDII; FEMALE; HUMAN; INCIDENCE; INFECTION RESISTANCE; IRAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MICROORGANISM DETECTION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SKIN BIOPSY; SPUTUM ANALYSIS; TERTIARY HEALTH CARE; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BURNS; CHILD; CIPROFLOXACIN; CITROBACTER FREUNDII; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; IMIPENEM; IRAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; WOUND INFECTION;

EID: 51149096000     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2007.12.008     Document Type: Article

References (42)

1. Revathi G., Puri J., and Jain B.K. Bacteriology of burns. Burns 24 (1998) 347-349
2. Bowler P.G., Duerden B.I., and Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14 (2001) 244-269
3. Mousa H.A., and Aerobic. anaerobic and fungal burn wound infections. J Hosp Infect 37 (1997) 317-322
4. Ramakrishnan K.M., Jayaraman V., Ramachandran K., and Mahdivanan T. The management of anaerobic infection in extensive burns. Burns 12 (1986) 270-272
5. Vrankova J., and Adamkova V. Bacteriological monitoring after burn injury. Acta Chir Plast 46 (2004) 48-50
6. Shahcheraghi F., Feizabadi M.M., Yamin V., Abiri R., and Abedian Z. Serovar determination, drug resistance patterns and plasmid profiles of Pseudomonas aeruginosa isolated from burn patients at two hospitals of Tehran (Iran). Burns 29 (2003) 547-551
7. Stratchounski L.S., Dekhnich A.V., Kretchikov V.A., Edelstain I.A., Narezkina A.D., Afinogenov G.E., et al. Antimicrobial resistance of nosocomial strains of Staphylococcus aureus in Russia: results of a prospective study. J Chemother 17 (2005) 54-60
8. Bauer W., Kirby W.M., Sherris J.C., and Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45 (1966) 493-496
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. (Eighth information supplement: NCCLS document M 100-S8.) Villanova, PA: National Committee for Clinical Laboratory Standards; 1998.
10. Agnihotri N., Gupta V., and Joshi R.M. Aerobic bacterial isolates from burn wound infections and their antibiograms-a five-year study. Burns 30 (2004) 241-243
11. Yildirim S., Nursal T.Z., Tarim A., Torer N., Noyan T., Demiroglu Y.Z., et al. Bacteriological profile and antibiotic resistance: comparison of findings in a burn intensive care unit, other intensive care units, and the hospital services unit of a single center. J Burn Care Rehabil 26 (2005) 488-492
12. Bagdonas R., Tamelis A., and Rimdeika R. Staphylococcus aureus infection in the surgery of burns. Medicina 39 (2003) 1078-1081
13. Altoparlak U., Erol S., Akcay M.N., Celebi F., and Kadanali A. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns 30 (2004) 660-664
14. Krishnan P.U., Miles K., and Shetty N. Detection of methicillin and mupirocin resistance in staphylococcus aureus isolates using conventional and molecular methods: a descriptive study from a burn unit with high prevalence of MRSA. J Clin Pathol 55 (2002) 745-748
15. Wei L.H., Zhang J., Deng J.J., Zou F.M., Liu G., and Si X.Q. The isolation of acintobacter strain from burn wound and the analysis of its antibiotic resistance. Zhonghua Shao Shang Za Zhi 20 (2004) 17-19
16. Sengupta S., Kumar P., Ciraj A.M., and Shivananda P.G. Acintobacter baumannii-an emerging nosocomial pathogen in the burn unit Manipal, India. Burns 27 (2001) 140-144
17. Arens S., and Verbist L. Differentiation and susceptibility of C. isolates from patients in a university hospital. Clin Microbiol Infect 3 (1997) 53-57
18. Chen Y.S., Wong W.W., Fung C.P., YU K.W., and Liu C.Y. Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia. J Microbiol Immunol Infect 35 (2002) 109-114
19. Shih C.C., Chen Y.C., Chang S.C., Luh K.T., and Hsieh W.C. Bacteremia due to C. species: significance of primary intraabdominal infection. Clin Infect Dis 23 (1996) 543-549
20. Ferreira A.C., Gobara S., Costa S.E., Sauaia N., Mamizuka E.M., van der Heijden I.M., et al. Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients. Infect Control Hosp Epidemiol 25 (2004) 868-872
21. Singh N.P., Goyal R., Manchanda V., das S., Kaur I., and Talwar V. Changing trends in bacteriology in the burn unit, Delhi, India. Burns 29 (2003) 129-132
22. Song W., Lee K.M., Kang H.J., Shin D.H., and Kim D.K. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns 27 (2001) 136-139
23. Kaushik R., Kumar S., Sharma R., and Lal P. Bacteriology of burn wounds-the first three years in a new burn unit at the medical college, Chandigarh. Burns 27 (2001) 595-597
24. Lari A.R., Honar H.B., and Alaghehbandan R. Pseudomonas infection in Tohid burn center, Iran. Burns 24 (1998) 637-641
25. Haberal M., Ucar N., Bayraktar U., Oner Z., and Bilgin N. Visceral injuries, wound infection and sepsis following electrical injuries. Burns 22 (1996) 158-161
26. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 34 (2002) 634-640
27. Shahid M., and Malik A. Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burn patients. Indian J Med Res 122 (2005) 324-329
28. Pirnay J.P., De Vos D., Cochez C., Bilocq F., Pirson J., Struelens M., et al. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: Persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 41 (2003) 1192-1202
29. Le Floch R., Arnould J.F., and Pilorget A. Effect of systemic empiric treatment with imipenem on the bacterial ecology in a burns unit. Burns 31 (2005) 866-869
30. Burwen D.R., Banerjee S.N., and Gaynes R.P. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis 170 (1994) 1622-1625
31. Pfaller M.A., Jones R.N., Marshall S.A., Coffman S.L., Hollis R.J., Edmond M.B., et al. Inducible amp C. beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 28 (1997) 211-219
32. Quinn J.P. Clinical significance of extended-spectrum betalactamases. Eur J Clin Microbiol Infect Dis 13 (1994) 39-42
33. Sanders Jr. W.E., and Sanders C.C. Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. Rev Infect Dis 10 (1988) 830-838
34. Vatopoulos A.C., Kalapothaki V., and Legakis N.J. Risk factors for nosocomial infections caused by gram-negative bacilli. The Hellenic antibiotic resistance study group. J Hosp Infect 34 (1996) 11-22
35. Sheridan R.L., Weber J.M., Pasternack M.S., and Tompkins R.G. Antibiotic prophylaxis for group A streptococcal burn wound infection is not necessary. J Trauma 51 (2001) 352-355
36. Desai M.H., Rutan R.L., Heggers J.P., and Herndon D.N. Candida infection with and without nystatin prophylaxis. An 11-year experience with patients with burn injury. Arch Surg 127 (1992) 159-162
37. Falk P.S., Winnike J., Woodmansee C., Desai M., and Mayhall II C.G. Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 21 (2000) 575-582
38. Roberts R.B., Tennenberg A.M., Eisner W., Hargrave J., Drusin L.M., Yurt R., et al. Outbreak in a New York city teaching hospital burn center caused by the Iberian epidemic clone of MRSA. Microb Drug Resist: Mech Epidemiol Dis 4 (1998) 175-183
39. Anonymous. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992 to June 2001, issued August 2001. Am J Infect Control 2001; 29:404-21.
40. Cunha B.A. Strategies to control antibiotic resistance. Semin Respir Infect 17 (2002) 250-258
41. Hall C.S., and Ost D.E. Effectiveness of programs to decrease antimicrobial resistance in the intensive care unit. Semin Respir Infect 18 (2003) 112-121
42. Nasser S., Mabrouk A., and Mather A. Colonization of burn wound in Ain Shams University burn unit. Burns 29 (2003) 229-233